01

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-01-15

UPADACITINIB

US Patent Number : 8962629

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3371

Patent Use Description :

Patent Expiration Date : 2031-01-15

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-10-17

UPADACITINIB

US Patent Number : 10550126

Drug Substance Claim :

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3298

Patent Use Description :

Patent Expiration Date : 2036-10-17

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-01-15

UPADACITINIB

US Patent Number : 8962629

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3624

Patent Use Description :

Patent Expiration Date : 2031-01-15

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-01-15

UPADACITINIB

US Patent Number : 8962629

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3624

Patent Use Description :

Patent Expiration Date : 2031-01-15

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-01-15

UPADACITINIB

US Patent Number : 8962629

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3624

Patent Use Description :

Patent Expiration Date : 2031-01-15

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-01-15

UPADACITINIB

US Patent Number : 8962629

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3946

Patent Use Description :

Patent Expiration Date : 2031-01-15

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-01-15

UPADACITINIB

US Patent Number : 8962629

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3945

Patent Use Description :

Patent Expiration Date : 2031-01-15

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-10-17

UPADACITINIB

US Patent Number : 11512092

Drug Substance Claim :

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3946

Patent Use Description :

Patent Expiration Date : 2036-10-17

Product Web Link

Corporate PDF

09

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-10-17

UPADACITINIB

US Patent Number : 11365198

Drug Substance Claim :

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3946

Patent Use Description :

Patent Expiration Date : 2036-10-17

Product Web Link

Corporate PDF

10

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-10-17

UPADACITINIB

US Patent Number : 11773106

Drug Substance Claim :

Drug Product Claim :

Application Number : 211675

Patent Use Code : U-3946

Patent Use Description :

Patent Expiration Date : 2036-10-17

Product Web Link

Corporate PDF

Upadacitinib

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers

9 USDMF

5 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

64 Drugs in Development

INTERMEDIATES

29 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers

4 FDA Orange Book

1 Europe

3 Canada

24 Australia

1 South Africa

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow

2 STOCK RECAP #PipelineProspector

133 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Finished Drug Prices

5 Annual Reports

MARKET PLACE

5 APIs

2 FDF Dossiers

PATENTS & EXCLUSIVITIES

94 US Patents

25 US Exclusivities

Filters

01

02

03

04

05

06

07

08

09

10